024b112f08a1c34e01af9a9932eb05c77e3d84a5
ARID1A.md
| ... | ... | @@ -7,7 +7,9 @@ link-citations: true |
| 7 | 7 | # ARID1A |
| 8 | 8 | |
| 9 | 9 | ## Overview |
| 10 | + |
|
| 10 | 11 | ARID1A (AT-rich interactive domain-containing protein 1A) is a gene that encodes a subunit of the SWI/SNF chromatin remodeling complex, which is involved in regulating DNA accessibility. Mutations in ARID1A are implicated in various cancers, including B-cell lymphomas. They are the most abundant in Burkitt lymphoma but also occur in FL and, to a lesser extent, DLBCL. |
| 12 | +Overall, components of SWI/SNF have been identified as an emerging theme in germinal centre-derived B-cell lymphomas but their role has not been thoroughly elucidated.[@lunningMutationChromatinModifiers2015b] |
|
| 11 | 13 | |
| 12 | 14 | ```mermaid |
| 13 | 15 | %%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%% |
morinlab.bib
| ... | ... | @@ -1,3 +1,23 @@ |
| 1 | +@article{lunningMutationChromatinModifiers2015b, |
|
| 2 | + title = {Mutation of Chromatin Modifiers; an Emerging Hallmark of Germinal Center {{B-cell}} Lymphomas}, |
|
| 3 | + author = {Lunning, M. A. and Green, M. R.}, |
|
| 4 | + date = {2015-10-16}, |
|
| 5 | + journaltitle = {Blood Cancer Journal}, |
|
| 6 | + shortjournal = {Blood Cancer J}, |
|
| 7 | + volume = {5}, |
|
| 8 | + number = {10}, |
|
| 9 | + eprint = {26473533}, |
|
| 10 | + eprinttype = {pmid}, |
|
| 11 | + pages = {e361}, |
|
| 12 | + issn = {2044-5385}, |
|
| 13 | + doi = {10.1038/bcj.2015.89}, |
|
| 14 | + abstract = {Subtypes of non-Hodgkin's lymphomas align with different stages of B-cell development. Germinal center B-cell (GCB)-like diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and Burkitt's lymphoma (BL) each share molecular similarities with normal GCB cells. Recent next-generation sequencing studies have gained insight into the genetic etiology of these malignancies and revealed a high frequency of mutations within genes encoding proteins that modifying chromatin. These include activating and inactivating mutations of genes that perform post-translational modification of histones and organize chromatin structure. Here, we discuss the function of histone acetyltransferases (CREBBP, EP300), histone methyltransferases (KDM2C/D, EZH2) and regulators of higher order chromatin structure (HIST1H1C/D/E, ARID1A and SMARCA4) that have been reported to be mutated in ⩾5\% of DLBCL, FL or BL. Mutations of these genes are an emerging hallmark of lymphomas with GCB-cell origins, and likely represent the next generation of therapeutic targets for these malignancies.}, |
|
| 15 | + langid = {english}, |
|
| 16 | + pmcid = {PMC4635197}, |
|
| 17 | + keywords = {Animals,Chromatin,Germinal Center,Histone Acetyltransferases,Histone Methyltransferases,Histone-Lysine N-Methyltransferase,Humans,Lymphoma Large B-Cell Diffuse,Mutation,Nuclear Proteins}, |
|
| 18 | + file = {/Users/rmorin/Zotero/storage/ETM7LAFC/Lunning and Green - 2015 - Mutation of chromatin modifiers; an emerging hallm.pdf} |
|
| 19 | +} |
|
| 20 | + |
|
| 1 | 21 | @article{witjesPrevalenceCytoplasmicActin2020b, |
| 2 | 22 | title = {Prevalence of {{Cytoplasmic Actin Mutations}} in {{Diffuse Large B-Cell Lymphoma}} and {{Multiple Myeloma}}: {{A Functional Assessment Based}} on {{Actin Three-Dimensional Structures}}}, |
| 3 | 23 | shorttitle = {Prevalence of {{Cytoplasmic Actin Mutations}} in {{Diffuse Large B-Cell Lymphoma}} and {{Multiple Myeloma}}}, |